Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria. - Meidan R; Nadal MA; Sosa BV; Lareo UC; Mittal P; Cohen H; Isenberg D (Lupus, 2026)